Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (2)

« Back to Publications

Multimorbidity, disease clusters and risk of all-cause and cause-specific mortality: a population-based prospective cohort study.

Littlejohns TJ. et al, (2025), Sci Rep, 15

Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Chisholm J. et al, (2024), Cancers (Basel), 16

Cookies on this website

Search results (2)

Multimorbidity, disease clusters and risk of all-cause and cause-specific mortality: a population-based prospective cohort study.

Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Leading Human Health Forward